유럽의 바이오인포매틱스 시장 : 제품 및 서비스별, 부문별, 용도별, 국가별 - 분석과 예측(2025-2035년)

This report can be delivered in 2 working days.

Introduction to Europe Bioinformatics Market

The Europe bioinformatics market is projected to reach $15.42 billion by 2035 from $4.27 billion in 2024, growing at a CAGR of 12.42% during the forecast period 2025-2035. In Europe, bioinformatics is an interdisciplinary field that combines computer science, biology, chemistry, mathematics, and statistics to evaluate complicated biological data. It is essential for comprehending the composition, operation, and development of biomolecules and systems, supporting research on protein interactions, disease gene identification, and gene expression analysis. Additionally, the field is essential for metabolic pathway research, precision medicine, and drug development. Next-generation sequencing technologies have accelerated the growth of genomic data, which has raised demand for bioinformatics tools in the healthcare and research sectors. AI and machine learning developments are improving data analysis even further, solidifying bioinformatics as a key component of European healthcare, genetics, and life sciences research.

Market Introduction

The market for bioinformatics in Europe is expanding significantly due to the growing need for sophisticated data analysis in systems biology, proteomics, and genomics. Researchers and medical professionals can comprehend molecular structures, gene activities, and protein interactions by using bioinformatics, which combines biology, chemistry, mathematics, statistics, and computer technology to manage and interpret complex biological datasets. Personalized medicine, drug discovery, illness gene identification, and the investigation of metabolic and signaling networks are some of its uses.

The market growth is propelled by the rapid expansion of genomic data, supported by developments in next-generation sequencing (NGS) technologies, high-throughput screening, and molecular diagnostics. The demand for bioinformatics solutions has increased due to the growing adoption of precision medicine programs throughout European nations, which allow for focused therapies and better patient outcomes. In order to improve productivity, shorten the time it takes to discover new drugs, and enable data-driven decision-making, research institutes, pharmaceutical corporations, and biotechnology companies are actively investing in bioinformatics platforms.

Bioinformatics analyses are becoming faster, more accurate, and more scalable thanks to technological advancements like cloud computing, artificial intelligence, and machine learning. The market is also being supported by government programs that encourage genomics research, innovation in the life sciences, and cooperative ventures around Europe. Bioinformatics is still a vital part of Europe's healthcare, genomics, and life sciences research environment, with room to develop and advance technologically despite obstacles such data security issues and the need for qualified experts.

Market Segmentation:

Segmentation 1: By Product and Services

• Bioinformatics Software and Tools
• Bioinformatics Services

Segmentation 2: By Sector

• Medical Biotechnology
• Animal Biotechnology
• Plant Biotechnology
• Forensic Biotechnology
• Others

Segmentation 3: By Application

• Genomics
• Proteomics
• Transcriptomics
• Metabolomics
• Others

Segmentation 4: By Region

• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest-of-Europe

Europe Bioinformatics Market Trends, Drivers and Challenges

Market Trends

• Increasing integration of AI and machine learning for faster, more accurate data analysis
• Growing use of cloud-based bioinformatics platforms for scalable data storage and collaboration
• Rising adoption of next-generation sequencing (NGS) and high-throughput technologies in genomics and proteomics research
• Expansion of precision medicine and personalized therapy programs across hospitals and research centers
• Enhanced application of bioinformatics in drug discovery, molecular diagnostics, and biomarker identification
• Growing collaborations between pharmaceutical companies, academic institutions, and technology providers to advance bioinformatics research

Market Drivers

• Rapid increase in genomic, proteomic, and metabolomic data requiring sophisticated analysis tools
• Rising demand for personalized medicine and targeted therapeutics in Europe
• Strong government and EU initiatives promoting life sciences research and genomics projects
• Expansion of biotechnology and pharmaceutical R&D activities in key European countries
• Technological advancements in AI, machine learning, and data analytics improving bioinformatics capabilities
• Need to reduce drug development timelines and enhance research efficiency

Market Challenges

• Shortage of skilled bioinformatics professionals to manage and interpret complex datasets
• High costs associated with advanced bioinformatics platforms and software
• Data privacy and security concerns, particularly with patient genomic information
• Integration challenges across diverse datasets and legacy systems
• Regulatory compliance complexities for clinical and healthcare bioinformatics applications

How can this report add value to an organization?

Product/Innovation Strategy: The Europe bioinformatics market has been extensively segmented based on various categories, such as product and services, sector, application, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The Europe bioinformatics market has numerous established players with product portfolios. Key players in the Europe bioinformatics market, analyzed and profiled in the study, include established players offering products and services for bioinformatics.

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• Eurofins Scientific
• Fios Genomics Ltd.
• QIAGEN
• SOPHiA GENETICS

Table of Contents

Executive Summary

Scope and Definition

1 Europe Bioinformatics Market: Industry Outlook

• 1.1 Market Trends: Current and Future Impact Assessment
  • 1.1.1 Strategic Integration of AI and ML in Bioinformatics Solutions
  • 1.1.2 Integration of Multi-Omics Data in the Bioinformatics Market
  • 1.1.3 Quantum Computing to Transform Bioinformatics
• 1.2 Regulatory Landscape
• 1.3 Pricing Analysis
• 1.4 Market Dynamics
  • 1.4.1 Market Drivers
    • 1.4.1.1 Rising Private and Public Investments in the Bioinformatics Industry
    • 1.4.1.2 Growing Demand for Bioinformatics in Drug Discovery
    • 1.4.1.3 Expanding Genomic Data Propelling the Demand for Bioinformatics Tools
  • 1.4.2 Market Challenges
    • 1.4.2.1 Data Complexity and Heterogeneity Limiting Bioinformatics Growth
    • 1.4.2.2 Ethical and Data Privacy Challenges Impacting Bioinformatics Adoption
  • 1.4.3 Market Opportunities
    • 1.4.3.1 Rising Importance of Metagenomics Offering Growth Potential for Bioinformatics

2 Bioinformatics Market, by Region, $Billion, 2023-2035

• 2.1 Europe
  • 2.1.1 Regional Overview
  • 2.1.2 Driving Factors for Market Growth
  • 2.1.3 Factors Challenging the Market
  • 2.1.4 Analyst View
  • 2.1.5 Market Sizing and Forecast
    • 2.1.5.1 Europe Bioinformatics Market (by Product and Services)
    • 2.1.5.2 Europe Bioinformatics Market (by Application)
    • 2.1.5.3 Europe Bioinformatics Market (by Sector)
    • 2.1.5.4 Europe Bioinformatics Market (by Country)
      • 2.1.5.4.1 U.K.
        • 2.1.5.4.1.1 Country Overview
        • 2.1.5.4.1.2 Driving Factors Market Growth
        • 2.1.5.4.1.3 Factors Challenging the Market
        • 2.1.5.4.1.4 Analyst View
        • 2.1.5.4.1.5 Market Sizing and Forecast
      • 2.1.5.4.2 Germany
        • 2.1.5.4.2.1 Country Overview
        • 2.1.5.4.2.2 Driving Factors Market Growth
        • 2.1.5.4.2.3 Factors Challenging the Market
        • 2.1.5.4.2.4 Analyst View
        • 2.1.5.4.2.5 Market Sizing and Forecast
      • 2.1.5.4.3 France
        • 2.1.5.4.3.1 Country Overview
        • 2.1.5.4.3.2 Driving Factors Market Growth
        • 2.1.5.4.3.3 Factors Challenging the Market
        • 2.1.5.4.3.4 Analyst View
        • 2.1.5.4.3.5 Market Sizing and Forecast
      • 2.1.5.4.4 Italy
        • 2.1.5.4.4.1 Country Overview
        • 2.1.5.4.4.2 Driving Factors Market Growth
        • 2.1.5.4.4.3 Factors Challenging the Market
        • 2.1.5.4.4.4 Analyst View
        • 2.1.5.4.4.5 Market Sizing and Forecast
      • 2.1.5.4.5 Spain
        • 2.1.5.4.5.1 Country Overview
        • 2.1.5.4.5.2 Driving Factors Market Growth
        • 2.1.5.4.5.3 Factors Challenging the Market
        • 2.1.5.4.5.4 Analyst View
        • 2.1.5.4.5.5 Market Sizing and Forecast
      • 2.1.5.4.6 Rest-of-Europe
        • 2.1.5.4.6.1 Regional Overview
        • 2.1.5.4.6.2 Driving Factors Market Growth
        • 2.1.5.4.6.3 Factors Challenging the Market
        • 2.1.5.4.6.4 Analyst View
        • 2.1.5.4.6.5 Market Sizing and Forecast

3 Competitive Benchmarking and Company Profiles

• 3.1 Company Profiles
  • 3.1.1 Eurofins Scientific
    • 3.1.1.1 Overview
    • 3.1.1.2 Top Products/Product Portfolio
    • 3.1.1.3 Top Competitors
    • 3.1.1.4 Target Customers
    • 3.1.1.5 Key Personnel
    • 3.1.1.6 Analyst View
  • 3.1.2 Fios Genomics
    • 3.1.2.1 Overview
    • 3.1.2.2 Top Products/Product Portfolio
    • 3.1.2.3 Top Competitors
    • 3.1.2.4 Target Customers
    • 3.1.2.5 Key Personnel
    • 3.1.2.6 Analyst View
  • 3.1.3 QIAGEN
    • 3.1.3.1 Overview
    • 3.1.3.2 Top Products/Product Portfolio
    • 3.1.3.3 Top Competitors
    • 3.1.3.4 Target Customers
    • 3.1.3.5 Key Personnel
    • 3.1.3.6 Analyst View
  • 3.1.4 SOPHiA GENETICS
    • 3.1.4.1 Overview
    • 3.1.4.2 Top Products/Product Portfolio
    • 3.1.4.3 Top Competitors
    • 3.1.4.4 Target Customers
    • 3.1.4.5 Key Personnel
    • 3.1.4.6 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast